LRRK2 expression linked to dopamine-innervated areas

Annals of Neurology

Volumn 59, Issue 4, 2006, Pages 714-719

  Gaiter, Dagmar ^a   Westerlund, Marie ^a   Carmine, Andrea ^a   Lindqvist, Eva ^a   Sydow, Olof ^b   Olson, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GENE PRODUCT; LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LRRK2 GENE; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUTAMEN; RAT; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; CASE-CONTROL STUDIES; DOPAMINE; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33645790701     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20808     Document Type: Article

References (13)

1. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
2. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
3. Dagerlind A, Friberg K, Bean AJ, et al. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 1992;98:39-49.
4. Blackinton JG, Galter D, Carmine A, et al. Cellular expression of PINK1, implicated in Parkinson's disease, in human, rat and mouse tissues. San Diego: Society for Neuroscience, 2004:1014.4.
5. Galter D, Westerlund M, Carmine A, et al. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents. Physiol Behav 2005 (in press).
6. Solano SM, Miller DW, Augood SJ, et al. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol 2000;47:201-210.
7. Buervenich S, Sydow O, Carmine A, et al. Alcohol dehydrogenase alleles in Parkinson's disease. Mov Disord 2000;15:813-818.
8. Buervenich S, Carmine A, Galter D, et al. A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol 2005;62:74-78.
9. Carmine A, Buervenich S, Sydow O, et al. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease. Mov Disord 2002;17:764-766.
10. Ross OA, Farrer MJ. Pathophysiology, pleotrophy and paradigm shifts: genetic lessons from Parkinson's disease. Biochem Soc Trans 2005;33:586-590.
11. Joyce JN, Ryoo HL, Beach TB, et al. Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors. Brain Res 2002;955:138-152.
12. Piggott MA, Marshall EF, Thomas N, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999;122(pt 8):1449-1468.
13. Braak H, Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-134.